Background: Symptomatic ankle osteoarthritis (OA) is a debilitating condition characterized by pain and functional impairment. Platelet-rich plasma (PRP) therapy has emerged as a potential treatment to alleviate symptoms and delay surgical interventions in ankle OA, akin to its established role in knee OA.
Materials and methods: A systematic search was conducted across major databases from inception to present, following preferred reporting items for systematic reviews and meta-analyses (PRISMA) guidelines. Studies assessing PRP therapy for ankle OA in adults were included. Data extraction and risk of bias assessment were performed using standardized tools. Meta-analyses were conducted where appropriate to synthesize outcomes, including visual analog scale (VAS) scores, American Orthopedic Foot and Ankle Society (AOFAS) scores, and Foot and Ankle Disability Index (FADI) scores.
Results: From 107 initial records, 6 studies met inclusion criteria, comprising 3 studies for meta-analysis. Platelet-rich plasma injections showed no significant reduction in VAS pain scores [standardized mean difference (SMD) 1.04, 95% CI, −0.95 to 3.02, p = 0.31]. However, significant improvements were observed in AOFAS scores (SMD 1.82, 95% CI, 0.79 to 2.86, p = 0.0006) and FADI scores (SMD −1.32, 95% CI, −2.01 to −0.63, p < 0.0001), indicating enhanced joint function and reduced disability.
Conclusion: Platelet-rich plasma therapy demonstrates potential benefits in improving functional outcomes and delaying surgical interventions for ankle OA. While pain reduction outcomes were inconclusive, significant improvements in joint function suggest PRP as a viable non-surgical treatment option. Standardization of protocols and larger randomized trials are warranted to further validate these findings and optimize clinical practice.
Glazebrook M, Daniels T, Younger A, et al. Comparison of health-related quality of life between patients with end-stage ankle and hip arthrosis. J Bone Joint Surg Am 2008;90(3):499–505. DOI: 10.2106/JBJS.F.01299
Witteveen AG, Hofstad CJ, Kerkhoffs GM. Hyaluronic acid and other conservative treatment options for osteoarthritis of the ankle. Cochrane Database Syst Rev 2015;2015(10):CD010643. DOI: 10.1002/14651858.CD010643.pub2
Vannini F, Di Matteo B, Filardo G, et al. Platelet-rich plasma for foot and ankle pathologies: a systematic review. Foot Ankle Surg 2014;20(1):2–9. DOI: 10.1016/j.fas.2013.08.001
Soomekh DJ. Current concepts for the use of platelet-rich plasma in the foot and ankle. Clin Podiatr Med Surg 2011;28(1):155–170. DOI: 10.1016/j.cpm.2010.09.001
Mei-Dan O, Carmont MR, Laver L, et al. Platelet-rich plasma or hyaluronate in the management of osteochondral lesions of the talus. Am J Sports Med 2012;40(3):534–541. DOI: 10.1177/0363546511431238
Vannini F, Di Matteo B, Filardo G. Platelet-rich plasma to treat ankle cartilage pathology—from translational potential to clinical evidence: a systematic review. J Exp Ortho 2015;2:1–0. DOI: 10.1186/s40634-015-0019-z
Kon E, Buda R, Filardo G, et al. Knee Surg Sports Traumatol Arthrosc. Platelet-rich plasma: intra-articular knee injections produced favourable results on degenerative cartilage lesions. 2010;18(4):472–479. DOI: 10.1007/s00167-009-0940-8
Kon E, Mandelbaum B, Buda R, et al. Platelet-rich plasma intra-articular injection versus hyaluronic acid viscosupplementation as treatments for cartilage pathology: from early degeneration to osteoarthritis. Arthroscopy 2011;27(11):1490–1501. DOI: 10.1016/j.arthro.2011.05.011
Ornetti P, Nourissat G, Berenbaum F, et al. Under the aegis of the Osteoarthritis Section of the French Society for Rheumatology (Société Française de Rhumatologie, SFR). Does platelet-rich plasma have a role in the treatment of osteoarthritis? Jt Bone Spine 2016;83(1):31–36. DOI: 10.1016/j.jbspin.2015.05.002
Laudy AB, Bakker EW, Rekers M, et al. Efficacy of platelet-rich plasma injections in osteoarthritis of the knee: a systematic review and meta-analysis. Br J Sports Med 2015;49(10):657–672. DOI: 10.1136/bjsports-2014-094036
Chang KV, Hsiao MY, Chen WS, et al. Effectiveness of intra-articular hyaluronic acid for ankle osteoarthritis treatment: a systematic review and meta-analysis. Arch Phys Med Rehabil 2013;94(5):951–960. DOI: 10.1016/j.apmr.2012.10.030
Vannabouathong C, Del Fabbro G, Sales B, et al. Intra-articular injections in the treatment of symptoms from ankle arthritis: a systematic review. Foot Ankle Int 2018;39(10):1141–1150. DOI: 10.1177/1071100718779375
Paget LDA, Reurink G, de Vos RJ, et al. Effect of platelet-rich plasma injections vs placebo on ankle symptoms and function in patients with ankle osteoarthritis: a randomized clinical trial. JAMA 2021;326(16):1595–1605. DOI: 10.1001/jama.2021.16602
Fukawa T, Yamaguchi S, Akatsu Y, et al. Safety and efficacy of intra-articular injection of platelet-rich plasma in patients with ankle osteoarthritis. Foot Ankle Int 2017;38(6):596–604. DOI: 10.1177/1071100717700377
Sun SF, Hsu CW, Lin GC, et al. Efficacy and safety of a single intra-articular injection of platelet-rich plasma on pain and physical function in patients with ankle osteoarthritis—a prospective study. J Foot Ankle Surg 2021;60(4):676–682. DOI: 10.1053/j.jfas.2020.12.003
Repetto I, Biti B, Cerruti P, et al. Conservative treatment of ankle osteoarthritis: can platelet-rich plasma effectively postpone surgery? J Foot Ankle Surg 2017;56(2):362–365. DOI: 10.1053/j.jfas.2016.11.015
Angthong C, Khadsongkram A, Angthong W. Outcomes and quality of life after platelet-rich plasma therapy in patients with recalcitrant hindfoot and ankle diseases: a preliminary report of 12 patients. J Foot Ankle Surg 2013;52(4):475–480. DOI: 10.1053/j.jfas.2013.04.005
Paget L, Bierma-Zeinstra S, Goedegebuure S, et al. Platelet-Rich plasma Injection Management for Ankle osteoarthritis study (PRIMA): protocol of a Dutch multicentre, stratified, block-randomised, double-blind, placebo-controlled trial. BMJ Open 2019;9(10):e030961. DOI: 10.1136/bmjopen-2019-030961s